Clinical Trials · NCT02058940
Intravenous Exenatide in Patients With Acute Brain Injury
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of North Carolina, Chapel Hill
- Enrollment
- 8
- Start date
- Aug 2015
- Locations
- 1 site, United States
- Primary endpoint
- Percentage of Critically Ill Patients With Acute Brain Injury Achieving Pre-specified Feasibility Criteria